SPOP and nonpapillary renal cell carcinoma: In these studies, although SPOP was shown to promote ccRCC tumorigenesis and progression, and small molecule compound 6b has been indicated to inhibit this process, the downstream signaling pathway controlled by SPOP is still unclear, which may be critical for an understanding of ccRCC pathogenesis8.